yoylqnqvwb
Cholerny Spammer
Joined: 03 Mar 2011
Posts: 729
Read: 0 topics
Location: England
|
 Posted: Sat 4:50, 12 Mar 2011 Post subject: nzu bwu lzi xpt |
|
|
Fluvastatin in type 2 diabetes mellitus patients with hypercholesterolemia antioxidant
Accountancy differences , which may be glycosylated degree of peroxidation and other factors . Previous studies have demonstrated that LDL is a type 2 diabetic atherosclerosis risk factors 【 9 】 , this study shows Fluvastatin can effectively lower LDL levels in vivo in patients , while levels as markers of lipid peroxidation in the TBARS and LHPO also Was significantly reduced . This shows that high oxidative stress in type 2 diabetes pathogenesis in patients with hyperlipidemia play an important role in the abnormal lipid metabolism in the formation of oxidative stress may be one important factor , and fluvastatin on hyperlipidemia In patients with type 2 diabetes role of oxidative stress and its anti- lipid-lowering effect of a certain relevance.
The post has been approved 0 times
|
|
FAQ
Search
Memberlist
Usergroups
Galleries
Register
Log in to check your private messages
Log in
